Drugs targeting the glucagon-like peptide-1 receptor (GLP-1R) demonstrated remarkable success in 2023, with approved products generating sales of $37.2 billion. Currently, there are 323 active GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback